Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 63 959 | déclaré | 19 mars 2026 | tx 47+540 644−134 978 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 18 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 125 | 68.71 USD | |
| 19 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 231 | 67.00 USD | |
| 17 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 4 084 | 69.42 USD | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 24 236 | — | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7 248 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 022 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7 176 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 17 161 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 27 310 | 0.00 USD | deriv |
| 19 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 261 | 47.40 USD | |
| 20 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 084 | 50.11 USD | |
| 18 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 3 341 | 46.29 USD | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 19 213 | — | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7 175 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7 248 | 0.00 USD | deriv |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30 628 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20 089 | 0.00 USD | deriv |
| 18 mars 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 4 436 | 30.60 USD | |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 12 038 | — | |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 7 248 | 0.00 USD | deriv |
| 15 mars 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 4 790 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 42 500 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 28 702 | 0.00 USD | deriv |